Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02351843 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of Low Amplitude Electroconvulsive Therapy
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02351843 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 1 participants.
The verdict
NCT02351843, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the clinical feasibility of low amplitude electroconvulsive therapy (ECT) to reduce, and possibly eliminate the side effects of ECT by lowering the strength of the ECT stimulus from the conventional 800 mA to 500 mA. Low amplitude ECT could potentially reduce the risks associated with ECT while preserving its unparalleled efficacy. This novel development would remove key obstacles to allow for the wider adoption of ECT as a safe and effective therapy.
Interventions
- DEVICE MECTA Spectrum 5000Q
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02351843
The ClinicalTrials.gov registry entry for NCT02351843 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MECTA Spectrum 5000Q is the first listed.
NCT02351843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02351843 about?
NCT02351843 is a clinical study titled "Efficacy and Safety of Low Amplitude Electroconvulsive Therapy". The purpose of this study is to demonstrate the clinical feasibility of low amplitude electroconvulsive therapy (ECT) to reduce, and possibly eliminate the side effects of ECT by lowering the strength of the ECT stimulus from the conventional 800 mA to 500 mA. Low amplitude ECT could potentially red...
What is the current status of trial NCT02351843?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2015-02. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02351843?
The interventions under investigation include: MECTA Spectrum 5000Q (DEVICE).
Who is sponsoring clinical trial NCT02351843?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.